ThomasNet News Logo
Sign Up | Log In | ThomasNet Home | Promote Your Business

BIO Conference to highlight drivers of biotech momentum.

Print | 
Email |  Comment   Share  
November 29, 2012 - Scheduled for Feb 11-12 in New York, 15th annual BIO CEO and Investor Conference will feature issue-oriented plenary sessions, educational sessions focused on timely therapeutic areas and key business issues, company presentations, one-on-one meetings, and networking opportunities. Conference focuses on public market biotech companies, which are having a banner year, substantially outperforming broader market indices. Nasdaq Biotech Index is up 27% year-to-date, beating S&P 500 by factor of 3.

15th Annual BIO CEO & Investor Conference to Highlight Drivers of Biotech Momentum


(Archive News Story - Products mentioned in this Archive News Story may or may not be available from the manufacturer.)

Biotechnology Industry Organization
1201 Maryland Ave., SW, Ste. 900
Washington, DC, 20024
USA



Press release date: November 27, 2012

BIO CEO & Investor Conference will be held February 11–12 in New York, NY

BIO CEO & Investor Conference
WASHINGTON--Now in its fifteenth year, the BIO CEO & Investor Conference, hosted by the Biotechnology Industry Organization (BIO), is the largest independent investor conference focused on publicly-traded biotechnology companies. Held in New York City, February 11 – 12, 2013, the event will feature issue-oriented plenary sessions, educational sessions focused on timely therapeutic areas and key business issues, company presentations, one-on-one meetings and networking opportunities.

“Many of the companies that fueled the tremendous performance of the NBI will be presenting at BIO CEO. This event is the first major East Coast biotech event for 2013, and is an invaluable opportunity for industry executives, as well as sector-specific and generalist investors”

The conference focuses on public market biotech companies, which are having a banner year, substantially outperforming the broader market indices. The Nasdaq Biotech Index (NBI) is up 27% year-to-date, beating the S&P 500 by a factor of 3. The sector’s climb has been driven by late-stage pipelines with impressive data and blockbuster potential, as well as positive trial data in orphan disease indications and over 30 innovative drug approvals so far this year.

“In addition to the sector’s overall public market performance, this year’s IPOs have had strong, positive performance similar to the index, giving private companies hope for successful market debuts. That, plus a return of pre-clinical IPOs and the passage of the JOBS Act indicate that the IPO window may be opening a bit wider than in recent years,” stated Alan Eisenberg, Executive Vice President, Emerging Companies and Business Development. This year, the conference will feature a new track of company presentations from late-stage private companies to better showcase the growth opportunities in this area of the industry. “Investors are increasingly finding value in pre-IPO companies, through crossover investing and other investment vehicles,” added Eisenberg.

“Many of the companies that fueled the tremendous performance of the NBI will be presenting at BIO CEO. This event is the first major East Coast biotech event for 2013, and is an invaluable opportunity for industry executives, as well as sector-specific and generalist investors,” added Eisenberg.

The robust conference program will also include Fireside Chats with industry leaders, Therapeutic Workshops focused on the latest pipeline innovations and breakthrough therapies, and Business Roundtables centered on examining investment and deal-making trends with seasoned industry executives and analysts. Additionally, the conference features presentations from over 130 publicly-traded biotechnology and pharmaceutical companies.

One-on-one meetings at this conference will be powered by BIO One-on-One Partnering™, an interactive environment to intelligently search, contact and schedule private meetings with potential partners and investors. Event attendees will have the opportunity to arrange meetings between investors, companies and industry executives. This industry-specific, web-based interactive software enables participants to move efficiently from the identification of prospective partners to discussion and negotiations.

Registration for the event is now open. Qualified institutional and venture investors whose primary activity is direct investment in research and development companies are eligible for complimentary registration. Equity research analysts from investment banking institutions also qualify as investors. Media registration also is complimentary for credentialed members of the media. All registrations are subject to verification of credentials.

BIO Industry Analysis offers the biotech industry market data to help guide decision making within the industry. The BIO Industry Analysis blog can be found here, and you can subscribe to future email newsletters here.

BIO is pleased to recognize the leadership provided by the BIO CEO & Investor Conference sponsors including supporting banks Stifel Nicolaus Weisel, Leerink Swann and ROTH Capital Partners, LLC.

About BIO
BIO represents more than 1,100 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces the BIO International Convention, the world’s largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world. BIO produces BIOtechNOW, an online portal and monthly newsletter chronicling “innovations transforming our world.” Subscribe to BIOtechNOW.

Upcoming BIO Events

BIO Asia International Conference
January 29 – 30, 2013
Tokyo, Japan

BIO CEO & Investor Conference
February 11 – 12, 2013
New York City, NY

BIO International Convention
April 22 – 25, 2013
Chicago, IL

World Congress on Industrial Biotechnology
June 16-19, 2013
Montreal, Canada

Contacts
Biotechnology Industry Organization
Abigail Hirsch, 1-202-962-9235
ahirsch@bio.org
Web: www.bio.org
Blog: www.biotech-now.org
Twitter: @IAmBiotech
Print | 
Email |  Comment   Share  
Contacts: View detailed contact information.


 

Post a comment about this story

Name:
E-mail:
(your e-mail address will not be posted)
Comment title:
Comment:
To submit comment, enter the security code shown below and press 'Post Comment'.
 



 See related product stories
More .....
 See more product news in:
Services
| Featured Manufacturing Jobs
 Other News from this company:
Senator Blunt Honored as BIO Legislator of the Year
Congressman Holt Honored as BIO Legislator of the Year
The Biotechnology Industry Organization and Biominas Brasil to Co-Host First Ever BIO Latin America Conference
Synthetic Biology Breaks New Ground on Renewable Chemicals
Partnering Opens for 2014 BIO International Convention with Record Number of Meetings Expected
More ....
 Tools for you
Watch Company 
View Company Profile
Company web site
More news from this company
E-mail this story to a friend
Save Story
Search for suppliers of
Trade Associations


Home  |  My ThomasNet News®  |  Industry Market Trends®  |  Submit Release  |  Advertise  |  Contact News  |  About Us
Brought to you by Thomasnet.com        Browse ThomasNet Directory

Copyright © 2014 Thomas Publishing Company. All Rights Reserved.
Terms of Use - Privacy Policy



Error close

Please enter a valid email address